MicroRNAs and Lung Cancer

ŠÁNA, Jiří and Ondřej SLABÝ. MicroRNAs and Lung Cancer. In Ondrej Slaby. MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets. New York: Nova Science Publishers, Inc., 2012, p. 95-110. ISBN 978-1-61324-514-9.

Basic information

Original name

MicroRNAs and Lung Cancer

Authors

ŠÁNA, Jiří (203 Czech Republic, guarantor, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution)

Edition

New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 95-110, 16 pp. 2012

Publisher

Nova Science Publishers, Inc.

---

Other information

Language

English

Type of outcome

Chapter(s) of a specialized book

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

Publication form

printed version "print"

RIV identification code

RIV/00216224:14740/12:00060172

Organization unit

Central European Institute of Technology

ISBN

978-1-61324-514-9

Keywords in English

microRNAs; lung cancer

Tags

ok, rivok

Tags

International impact, Reviewed

---

Abstract

In the original language

Lung cancer is one of the most common cancers in the world. Alterations in microRNA (miRNA) funtionality are frequently found in malignancies, including lung cancer. In this chapter, we summarize the current understanding of miRNAs in lung cancer pathogenesis, and highlight their potential in early diagnosis, in extending histological sub-classification techniques, in overcoming drug resistance, and serving not only as biomarkers for risk stratification and outcome prediction, but also as potential therapeutic targets in lung cancer.

---

Links

ED1.1.00/02.0068, research and development project

Name: CEITEC - central european institute of technology